# TRUSELTIQ
> **NDA214622** · New Drug Application · Sponsor: HELSINN HLTHCARE · Approved 2021-05-28
## Drug
- **FDA Application Number:** NDA214622
- **Application type:** New Drug Application
- **Brand name:** TRUSELTIQ
- **Generic name:** Infigratinib Phosphate
- **Active ingredients:** INFIGRATINIB PHOSPHATE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** HELSINN HLTHCARE
- **First approval:** 2021-05-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=214622)
---
*MORVS · CC0 1.0*